COSM
Cosmos Health Inc.

14,016
Mkt Cap
$22.3M
Volume
29,074.00
52W High
$1.32
52W Low
$0.2801
PE Ratio
-0.89
COSM Fundamentals
Price
$0.63
Prev Close
$0.6334
Open
$0.63
50D MA
$0.9138
Beta
1.24
Avg. Volume
1.24M
EPS (Annual)
-$1.17
P/B
0.87
Rev/Employee
$365,277.87
Loading...
Loading...
News
all
press releases
Insider Buying: Cosmos Health (NASDAQ:COSM) CEO Buys $35,111.16 in Stock
Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas bought 55,732 shares of the stock in a transaction that occurred on Tuesday, November 25th. The shares were bought at an...
MarketBeat·23h ago
News Placeholder
More News
News Placeholder
Grigorios Siokas Buys 51,315 Shares of Cosmos Health (NASDAQ:COSM) Stock
Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas purchased 51,315 shares of Cosmos Health stock in a transaction on Thursday, November 20th. The stock was bought at an average...
MarketBeat·6d ago
News Placeholder
Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Purchases 61,614 Shares
Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas acquired 61,614 shares of the company's stock in a transaction on Wednesday, November 19th. The stock was purchased at an...
MarketBeat·7d ago
News Placeholder
Cosmos Health Announces Launch Of Food Supplement Brand In Albania: Retail Sentiment Improves
The company said that the launch is in partnership with Tirana-based pharmaceutical company Pharma Cell, which will serve as the distributor in the country.
Stocktwits·8mo ago
News Placeholder
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc. Virax Biolabs Announces...
PR Newswire·1y ago
News Placeholder
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform
CHICAGO, IL / ACCESSWIRE / March 21, 2024 / Cosmos Health Inc. ('Cosmos Health' or the 'Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...
Accesswire·2y ago
News Placeholder
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
CHICAGO, IL / ACCESSWIRE / March 19, 2024 / Cosmos Health Inc. ('Cosmos Health' or the 'Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...
Accesswire·2y ago
News Placeholder
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
CHICAGO, IL / ACCESSWIRE / March 18, 2024 / Cosmos Health Inc. ('Cosmos Health' or the 'Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...
Accesswire·2y ago
News Placeholder
Cosmos Holdings completes acquisition of Pharmatrade assets
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Cosmos Health Successfully Completes Acquisition of Pharmatrade's Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million
CHICAGO, IL / ACCESSWIRE / February 29, 2024 / Cosmos Health Inc. ('Cosmos Health' or the 'Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...
Accesswire·2y ago

Latest COSM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.